Mixed Martial Arts - A Controversial Combat Sport
The risks associated with the practice of mixed martial arts (MMA) should always be assessed with a high level of attention. The practice of this sport, however, does not yet say everything about the risk potential.
Predictive Models – Again
Indirect use of discrimination factors that are outlawed is inexcusable and needs to be avoided by due diligence by insurer and indeed the firm supplying the data. Any decent carrier would not want to cross those red lines anyway – and that is even if the data company involved is not itself subject to regulatory oversight and/or consumer protection laws. Moral: act with integrity and choose your business partners carefully.
Fitness and Health Apps may be Sharing the Most Private Details about your Life
There’s not enough oversight for apps that track everything from people’s fitness routines to their menstrual cycles, bioethicists say.
Why the Life-Insurance Industry Wants to Creep on Your Instagram
Insurers are using customers’ social-media posts to determine premiums, inviting the potential for our digital lives to become disingenuous performances.
Insurtech – and the Game-changer is…?
‘Insurtech’: our inboxes are full of news alerts, and hardly a day passes without a notable insurer or reinsurer somewhere commencing a digital initiative, applying artificial intelligence, partnering with a hi-tech high-flyer or investing in a digital/data/analytics start-up. Insurtech is big these days.
The Past, Present, and Future of Opioid-Related Mortality
Slides for the presentation at ReFocus 2019, March 10-13, Las Vegas
Hearts, Relationships, and Life Insurance
In this age of amazing medical advances, it seems as though anything broken can be fixed. In my native South Africa, the surgeon Dr. Christiaan Barnard proved that even defective hearts can be replaced when he performed the first heart transplant in 1967.
Cancer and the Statistic of One
Rapid medical advances, as well as growing volumes of health and mortality data, are transforming cancer risk assessment. RGA's Neil Parkin explores our deepening understanding and insurance implications.